Emergency War Surgery NATO Handbook: Part III: General Considerations of Wound
Management: Chapter XV: Anesthesia and Analgesia
Induction of Anesthesia
United States Department of Defense
Time constraints and the risk of aspiration usually dictate that induction be rapid and
controlled. Several intravenous agents are available which are in common use in the trauma
setting. These include the rapidly acting barbiturates (such as thiopental), the
benzodiazepines, rapidly acting narcotics, etomidate, and ketamine The overriding factors
in the decision as to which drug is best relate to the adequacy of blood volume, history
of allergic reaction, or recent food intake If the patient is markedly hypovolemic and
there is insufficient time for fluid resuscitation, it is best to modify dosages of
induction agents or use less cardiovascular depressant drugs, such as narcotics,
etomidate, or ketamine. "Normal" dosages become lethal doses in the hypovolemic
patient.
Some of the more important induction agents are:
Thiopental. This rapidly-acting barbiturate is quite familiar to most present
day anesthetists. It has the advantages of fast onset, short duration, and good patient
acceptance However, normal induction dosages may cause disastrous hypotension in the
hypovolemic patient. An induction dose is 3-4 mg/kg intravenously, given over one minute
in a solution of 2.5% or less in normal saline. This drug can be a potent cardiac
depressant and can produce hypotension. It can cause laryngospasm immediately after or
during induction, is a poor analgesic, and produces poor muscle relaxation. This drug is
best used in combination with a muscle relaxant paralytic drug.
Etomidate. This drug usually preserves cardiovascular stability in the intact
elective surgical patient but probably has no advantage over thiopental. in the case of
hypovolemia. It also produces localized pain and myoclonic movements on rapid injection.
Ketamine. This agent is also fast acting, has analgesic properties, and supports
the blood pressure by sympathetic stimulation. However, one must still be wary in the
severely hypovolemic patient in whom sympathetic outflow may already be near maximal
intensity. In these cases, the direct depressant effect on the myocardium may produce
decreased cardiac output. Postoperative excitement and dysphoria, which is produced at
times by this drug, may be minimized by using lower dosages or giving small amounts of
benzodiazepines in combination with ketamine
Narcotics. Rapidly acting narcotics, such as sufentanil, in conjunction with
benzodiazepines are an alternative induction technique. If newer agents, such as the
narcotic alfentanil, and the benzodiazepine midazolam. prove safe in trauma cases, they
should be considered also.
Regardless of the induction agent chosen, the risk of aspiration during induction (and
emergence) remains a critical consideration. Drugs such as histamine receptor blockers,
metaclopramide, and nonparticulate antacids offer promise as prophylactic measures;
however, these agents will not be available on the battlefield, and the rapid and secure
control of the airway remains the primary means of preventing this grave complication.
The anesthetist must ensure that an adequately functioning suction apparatus is close
at hand and operational prior to induction or emergence.
Approved for public release; Distribution is unlimited.
The listing of any non-Federal product in this CD is not an
endorsement of the product itself, but simply an acknowledgement of the source.
Operational Medicine 2001
Health Care in Military Settings
Bureau of Medicine and Surgery
Department of the Navy
2300 E Street NW
Washington, D.C
20372-5300 |
Operational Medicine
Health Care in Military Settings
CAPT Michael John Hughey, MC, USNR
NAVMED P-5139
January 1, 2001 |
United States Special Operations Command
7701 Tampa Point Blvd.
MacDill AFB, Florida
33621-5323 |
This web version is provided by
The Brookside Associates Medical
Education Division. It contains original contents from the official US
Navy NAVMED P-5139, but has been reformatted for web access and includes
advertising and links that were not present in the original version. This web
version has not been approved by the Department of the Navy or the Department of
Defense. The presence of any advertising on these pages does not constitute an
endorsement of that product or service by either the US Department of Defense or
the Brookside Associates. The Brookside Associates is a private organization,
not affiliated with the United States Department of Defense.
Contact Us · ·
Other Brookside Products
|